GUILLAIN-BARRE SYNDROME
Clinical trials for GUILLAIN-BARRE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new GUILLAIN-BARRE SYNDROME trials appear
Sign up with your email to follow new studies for GUILLAIN-BARRE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to halt rapid nerve damage in GBS
Disease control Recruiting nowThis study is testing a single dose of an investigational drug called tanruprubart (ANX005) in people recently diagnosed with Guillain-Barré syndrome (GBS). The main goals are to see how the drug behaves in the body, if it is safe, and to look for early signs that it might help c…
Matched conditions: GUILLAIN-BARRE SYNDROME
Phase: PHASE3 • Sponsor: Annexon, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug trial aims to tame sudden nerve attack
Disease control Recruiting nowThis study is testing if a drug called efgartigimod is safe and can help people with Guillain-Barré Syndrome (GBS), a serious condition where the immune system attacks the nerves. It will involve about 30 adults who recently developed GBS weakness. Researchers will compare patien…
Matched conditions: GUILLAIN-BARRE SYNDROME
Phase: PHASE2 • Sponsor: Chafic Karam • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC